Search Results

• • 18 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Erlotinib-associated rash in patients with EGFR mutation-positive non-small-cell lung cancer treated in the EURTAC trial

  Authors:Filippo de Marinis, Alain Vergnenegre, Antonio Passaro, Catherine Dubos-Arvis, Enric Carcereny, Ana Drozdowskyj, et al.From:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20154,971 words Clinical report 1690LAuthor(s): Filippo de Marinis [*] aff1 aff2 , Alain Vergnenegre aff3 , Antonio Passaro aff1 aff2 , Catherine Dubos-Arvis aff4 , Enric Carcereny aff5 , Ana Drozdowskyj aff6 , Ali Zeaiter aff7 , Pablo Perez-Moreno aff7 ,...

• Evaluating treatments and corresponding costs of prostate cancer patients treated within an inpatient or hospital-based outpatient setting

  Authors:Brian Seal, Sean D Sullivan, Scott Ramsey, Carl V Asche, Kenneth M Shermock, Syam Sarma, et al.From:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20154,990 words Report 1690LAuthor(s): Brian Seal aff1 , Sean D Sullivan aff2 , Scott Ramsey aff3 , Carl V Asche aff4 , Kenneth M Shermock aff5 , Syam Sarma aff6 , Erin Zagadailov aff7 , Eileen Farrelly aff7 , Michael Eaddy [*] aff7 KEYWORDS...

• Metastasis-related miRNAs: a new way to differentiate patients with higher risk?

  Authors:Athina Markou, Evi Lianidou, and Vassilis GeorgouliasFrom:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20152,011 words Editorial 2040LAuthor(s): Athina Markou aff1 , Evi Lianidou aff1 , Vassilis Georgoulias [*] aff2 KEYWORDS circulating miRNAs; liquid biopsy; metastasis; miRNAs; tumor biomarkers Metastasis refers to the spread of cancer cells...

• The use of novel agents in multiple myeloma patients with hepatic impairment

  Authors:Lindsay C Stansfield, Wilson I Gonsalves, and Francis K BuadiFrom:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20156,817 words Report 1940LAuthor(s): Lindsay C Stansfield aff1 , Wilson I Gonsalves [*] aff2 , Francis K Buadi aff2 KEYWORDS hepatic impairment; myeloma; novel agents Multiple myeloma (MM) is a clonal plasma cell disorder, which...

• Radiotherapy for cutaneous melanoma: current and future applications

  Authors:Peter Gorayski, Bryan Burmeister, and Matthew FooteFrom:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20157,588 words Report 2070LAuthor(s): Peter Gorayski aff1 , Bryan Burmeister aff1 aff2 , Matthew Foote [*] aff1 aff2 KEYWORDS cutaneous; melanoma; radiation therapy; radiotherapy; targeted therapies In 2014, melanoma accounted for 76,100...

• Refining sorafenib therapy: lessons from clinical practice

  Authors:Luigi Bolondi, Antonio Craxi, Franco Trevisani, Bruno Daniele, Giovan Giuseppe Di Costanzo, Stefano Fagiuoli, et al.From:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 201510,987 words Report 1940LAuthor(s): Luigi Bolondi [*] aff1 , Antonio Craxi aff2 , Franco Trevisani aff3 , Bruno Daniele aff4 , Giovan Giuseppe Di Costanzo aff5 , Stefano Fagiuoli aff6 , Calogero Cammà aff7 , Paolo Bruzzi aff8 , Romano Danesi...

• Icotinib, a selective EGF receptor tyrosine kinase inhibitor, for the treatment of non-small-cell lung cancer

  Authors:Fenlai Tan, Yuankai Shi, Yinxiang Wang, Lieming Ding, Xiaobin Yuan, and Yan SunFrom:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20158,969 words Report 1970LAuthor(s): Fenlai Tan aff1 , Yuankai Shi aff2 , Yinxiang Wang aff1 , Lieming Ding aff1 , Xiaobin Yuan aff1 , Yan Sun [*] aff2 KEYWORDS EGF receptor tyrosine kinase inhibitors; icotinib; molecular targeted therapy;...

• Everolimus in diffuse large B-cell lymphomas.

  Authors:Michele Merli, Andrea Ferrario, Margherita Maffioli, Luca Arcaini, and Francesco PassamontiFrom:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20157,210 words Report 1730LABSTRACT Satisfactory treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) is not currently available and novel therapies are needed. mTOR is an intracellular kinase that is part of an aberrantly...

• Circulating biomarker panels for targeted therapy in brain tumors

  Authors:Cristiana Tanase, Radu Albulescu, Elena Codrici, Ionela Daniela Popescu, Simona Mihai, Ana Maria Enciu, et al.From:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 201510,011 words Report 2040LAuthor(s): Cristiana Tanase [*] aff1 , Radu Albulescu aff1 aff2 , Elena Codrici aff1 , Ionela Daniela Popescu aff1 , Simona Mihai aff1 , Ana Maria Enciu aff1 aff3 , Maria Linda Cruceru aff3 , Adrian Claudiu Popa aff3 ,...

• Advantages of staging laparoscopy in gastric cancer: they are so obvious that they are not evident

  Authors:Stefano Rausei, Laura Ruspi, Alberto Mangano, Georgios D Lianos, Federica Galli, Luigi Boni, et al.From:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20152,341 words Editorial 1680LAuthor(s): Stefano Rausei [*] aff1 , Laura Ruspi aff1 , Alberto Mangano aff1 , Georgios D Lianos aff2 , Federica Galli aff1 , Luigi Boni aff1 , Dimitrios H Roukos aff2 , Gianlorenzo Dionigi aff1 KEYWORDS gastric...

• Genitourinary small cell malignancies: prostate and bladder

  Authors:Kashyap Shatagopam, Hristos Z Kaimakliotis, Liang Cheng, and Michael O KochFrom:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20157,476 words Report 2430LAuthor(s): Kashyap Shatagopam aff1 , Hristos Z Kaimakliotis [*] aff1 , Liang Cheng aff2 , Michael O Koch aff1 KEYWORDS bladder cancer; chemotherapy; prostate cancer; radiotherapy; small cell carcinoma; surgery...

• Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysis

  Authors:Sanjay Popat, Anders Mellemgaard, Kyle Fahrbach, Alison Martin, Maria Rizzo, Rolf Kaiser, et al.From:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20156,023 words Report 1710LAuthor(s): Sanjay Popat [*] aff1 , Anders Mellemgaard aff2 , Kyle Fahrbach aff3 , Alison Martin aff4 , Maria Rizzo aff4 , Rolf Kaiser aff5 , Ingolf Griebsch aff5 , Martin Reck aff6 KEYWORDS adenocarcinoma;...

• Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice

  Authors:Alessandra Fabi, Luca Moscetti, Mariangela Ciccarese, Miriam Caramanti, Nello Salesi, Nicla La Verde, et al.From:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20154,805 words Report 1480LAuthor(s): Alessandra Fabi [*] aff1 , Luca Moscetti aff2 , Mariangela Ciccarese aff3 , Miriam Caramanti aff4 , Nello Salesi aff5 , Nicla La Verde aff6 , Michelangelo Russillo aff7 , Daniele Generali aff8 , Giuseppina...

• Diagnostic challenges in non-small-cell lung cancer: an integrated medicine approach

  Author:Ravi SalgiaFrom:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20157,936 words Report 2130LAuthor(s): Ravi Salgia [*] KEYWORDS ALK inhibitor; EGFR inhibitor; integrated medicine; molecular diagnostics; molecular profile; multidisciplinary forum; non-small-cell lung cancer; personalized medicine Lung...

• Corrigendum

  From:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 2015349 words Correction notice 740LFollowing publication of the Review by Christine M Bestvina, Leah L Zullig & S Yousuf Zafar, titled 'The implications of out-of-pocket cost of cancer treatment in the USA: a critical appraisal of the literature', which...

• Economic evaluation of prostate cancer screening: a systematic review

  Authors:Chunhuan Lao, Charis Brown, Paul Rouse, Richard Edlin, and Ross LawrensonFrom:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20156,800 words Report 1710LAuthor(s): Chunhuan Lao [*] aff1 , Charis Brown aff1 , Paul Rouse aff2 , Richard Edlin aff3 , Ross Lawrenson aff1 KEYWORDS cost; cost-effectiveness threshold; economic evaluation; prostate cancer; quality of life;...

• Three-tiered nodal classification system for bladder cancer: a new proposal

  Authors:Jose A Pedrosa, Michael O Koch, Hristos Z Kaimakliotis, M Francesca Monn, Timothy A Masterson, Kevin R Rice, et al.From:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20155,384 words Report 1560LAuthor(s): Jose A Pedrosa aff1 , Michael O Koch aff1 , Hristos Z Kaimakliotis aff1 , M Francesca Monn aff1 , Timothy A Masterson aff1 , Kevin R Rice aff1 , K Clint Cary aff1 , Richard S Foster aff1 , Richard Bihrle aff1...

• TRAIL-based therapy in pediatric bone tumors: how to overcome resistance

  Authors:Romain Guiho, Kevin Biteau, Dominique Heymann, and Francoise RediniFrom:Future Oncology (Vol. 11, Issue 3) Peer-Reviewed

  Feb. 20155,292 words Report 2000LAuthor(s): Romain Guiho aff1 aff2 aff3 , Kevin Biteau aff1 aff2 aff3 , Dominique Heymann aff1 aff2 aff3 , Françoise Redini [*] aff1 aff2 aff3 KEYWORDS Ewing's sarcoma; microenvironment; osteosarcoma; resistance;...